Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow conversion efficiency. Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.12 Million ≈ $1.33 Million USD) by net assets (CN¥910.35 Million ≈ $133.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)

Cash flow conversion efficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300942 share price today for real-time trading data and today's change.

Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Conversion Ratio Explained

Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their cash flow conversion efficiency. Also see Shenzhen Bioeasy Biotechnology Co. Ltd. market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Jiangsu Nanfang Medical SHG:603880	0.077x
Frontera Energy Corp TO:FEC	-0.019x
Dhani Services Limited NSE:DHANI	0.010x
Chongqing Sansheng Building Materials Co Ltd SHE:002742	0.019x
FS Bancorp Inc NASDAQ:FSBW	0.163x
Morguard Real Estate Investment Trust TO:MRT-UN	0.002x
ALPHA KLSE:0303	0.054x
Hamilton Beach Brands Holding Co Class A NYSE:HBB	0.284x

Annual Cash Flow Conversion Efficiency for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. Review Shenzhen Bioeasy Biotechnology Co. Ltd. free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥907.68 Million ≈ $132.82 Million	CN¥66.87 Million ≈ $9.79 Million	0.074x	+87.15%
2024-12-31	CN¥870.24 Million ≈ $127.34 Million	CN¥34.26 Million ≈ $5.01 Million	0.039x	+189.70%
2023-12-31	CN¥848.73 Million ≈ $124.20 Million	CN¥-37.25 Million ≈ $-5.45 Million	-0.044x	-127.75%
2022-12-31	CN¥964.70 Million ≈ $141.17 Million	CN¥152.55 Million ≈ $22.32 Million	0.158x	-41.40%
2021-12-31	CN¥946.58 Million ≈ $138.51 Million	CN¥255.42 Million ≈ $37.38 Million	0.270x	+132.21%
2020-12-31	CN¥548.98 Million ≈ $80.33 Million	CN¥63.79 Million ≈ $9.34 Million	0.116x	-8.70%
2019-12-31	CN¥528.32 Million ≈ $77.31 Million	CN¥67.24 Million ≈ $9.84 Million	0.127x	-51.09%
2018-12-31	CN¥222.62 Million ≈ $32.58 Million	CN¥57.93 Million ≈ $8.48 Million	0.260x	+26.35%
2017-12-31	CN¥114.60 Million ≈ $16.77 Million	CN¥23.60 Million ≈ $3.45 Million	0.206x	-68.67%
2016-12-31	CN¥55.24 Million ≈ $8.08 Million	CN¥36.31 Million ≈ $5.31 Million	0.657x	--

About Shenzhen Bioeasy Biotechnology Co. Ltd.

SHE:300942 China Biotechnology

Market Cap

$342.02 Million

CN¥2.34 Billion CNY

Market Cap Rank

#13939 Global

#4101 in China

Share Price

CN¥5.77

Change (1 day)

+1.23%

52-Week Range

CN¥5.69 - CN¥11.11

All Time High

CN¥40.28